Financial Health Snapshot
What does AMETEK’s latest financial snapshot show?
Strong. The clearest strength is cash conversion and margin quality, while the main concern is the roughly $500B in cash planned for the Indicor Instrumentation portfolio acquisition.
For FY2025 and the latest Q1 2026 update, this view combines growth, profitability, cash generation, balance-sheet capacity, and capital efficiency. AMETEK’s mission and strategy context also helps frame the numbers, and Mission Statement, Vision, & Core Values (2026) of AMETEK, Inc. (AME) gives that backdrop.
Among these, free cash flow deserves the first deeper analysis because it best shows how AMETEK can fund growth, debt, and acquisitions.
Revenue and Earnings Quality
Does AMETEK’s revenue growth support quality earnings?
Strong. FY2025 and Q1 2026 both showed higher sales, but the clearest confirmation is that earnings and adjusted EPS also rose, while Q1 2026 orders and backlog improved visibility.
AMETEK’s growth looks more like durable earnings expansion than simple top-line growth. Investors compare revenue with operating income, net income, and EPS across the same annual periods to see whether sales are turning into real profit, not just bigger reported revenue. For background, see AMETEK, Inc. (AME): History, Ownership, Mission, How It Works & Makes Money.
| Measure | Latest Period | Previous Period | Quality Test | Investor Meaning |
|---|---|---|---|---|
| Revenue | $740B, 66% increase, FY2025 | $740B was not provided for FY2024 in the prompt | Growth source is mixed but supported by both acquisitions and operating momentum | The increase looks repeatable enough to matter, especially with recurring support revenue and added scale |
| Operating Income | Latest verified operating income was not provided | Previous comparable value was not provided | Unable to verify whether operating income grew faster or slower than revenue | Investors cannot fully test operating leverage from the supplied data alone |
| Net Income | $148B, FY2025, 756% growth year-over-year | Previous comparable value was not provided | Verified growth was supported by stronger operating performance, but the exact bridge is not provided | The sharp rise confirms the revenue trend translated into much stronger bottom-line earnings |
| Diluted EPS | $640, FY2025; $174 in Q1 2026 GAAP diluted EPS and $197 adjusted diluted EPS | Prior FY diluted EPS was not provided; Q1 2025 GAAP diluted EPS was $175 | Per-share results improved, and the Q1 comparison shows the business delivered growth despite a slightly lower GAAP base | Shareholders received earnings growth that broadly matched the business trend |
How durable is AMETEK’s revenue growth?
Quite durable so far. The strongest signal is $220B Q1 2026 orders, 23% higher year-over-year, plus $387B backlog. The main limitation is that the prompt does not break out concentration by customer, product, or geography.
- Demand Quality: Recurring revenue from consumables, services, and aftermarket support adds stability, and orders plus backlog improve near-term visibility.
- Pricing and Volume: The price-volume split is not provided, so the growth driver cannot be separated cleanly from the supplied data.
- Diversification: Growth was supported by EIG, EMG, FARO Technologies, Kern Microtechnik, LKC Technologies, First Aviation Services, and pending Indicor Instrumentation, but concentration data is not provided.
That combination is a useful starting point for profitability and cash conversion analysis.
Profitability and cash quality
Are AMETEK, Inc.'s profits supported by cash flow?
Yes. AMETEK, Inc. showed stronger operating profitability in FY2025, with adjusted operating margin at 262%, and cash flow clearly supported earnings: FY2025 free cash flow was $170B, or 113% of net income. That is a strong profit-to-cash result.
Gross, operating, and net margins measure different layers of profitability, but net income alone does not show cash quality. For AMETEK, Inc., FY2025 GAAP operating income of $191B, adjusted operating income of $194B, and FY2025 net income of $148B were reinforced by free cash flow, while capital spending stayed modest. The mission and values context is here: Mission Statement, Vision, & Core Values (2026) of AMETEK, Inc. (AME).
| Measure | Latest Period | Previous Period | Verified Driver | Investor Meaning |
|---|---|---|---|---|
| Gross Margin | Unavailable | Unavailable | No verified gross margin figure was supplied. | Product economics cannot be confirmed from the supplied data. |
| Operating Margin | FY2025 adjusted operating margin of 262% | Unavailable | Adjusted operating income of $194B versus GAAP operating income of $191B | Scale appears to support very strong operating efficiency. |
| Net Margin | Unavailable | Unavailable | No verified net margin figure was supplied. | Final profitability cannot be measured directly from the supplied margin data. |
| Operating Cash Flow | Unavailable | Unavailable | No verified operating cash flow figure was supplied. | Cash conversion from operations cannot be checked directly here. |
| Free Cash Flow | FY2025 free cash flow of $170B | Unavailable | FY2025 free cash flow conversion of 113% of net income | Reported earnings converted well into cash, leaving room for reinvestment and financing. |
What most affects AMETEK, Inc.'s cash conversion?
The strongest verified driver is AMETEK, Inc.'s high free cash flow conversion, helped by modest stated capital intensity and acquisition-related amortization; that looks mostly structural, not temporary.
- Main Driver: Free cash flow conversion is expected at 110% to 115% of net income, supported by capex near $1600M, or 2% of sales.
- Evidence Gap: The supplied data does not verify operating cash flow or gross margin for direct period-to-period comparison.
- Metric to Monitor: Watch free cash flow conversion and capital expenditures versus sales.
Flexible Liquidity
Is AMETEK, Inc. (AME)’s balance sheet liquid enough for its funding needs?
Mixed to Strong. AMETEK, Inc. (AME) has flexible liquidity and management says capital deployment capacity exceeds $500B while still targeting investment-grade credit ratings. The main protection is operating cash generation and staggered debt management; the main concern is acquisition funding, including the planned $500B Indicor Instrumentation deal.
Cash alone does not tell the full story. AMETEK, Inc. (AME) also needs enough working capital, asset quality, debt service capacity, solvency, liquidity, and refinancing access to fund operations and acquisitions without stress. For readers comparing strategy and capital structure, Mission Statement, Vision, & Core Values (2026) of AMETEK, Inc. (AME) helps connect balance-sheet discipline with broader corporate priorities.
| Area | Latest Evidence | Assessment | Investor Meaning |
|---|---|---|---|
| Cash and Working Capital | 2026-03-31 Minus Cash And Cash Equivalents: $48125M; operating working capital at 165% of sales, up 30 basis points year over year. | Strong | Near-term obligations look manageable, and working-capital efficiency supports continued investment. |
| Total and Net Debt | Add Total Debt: $218B; cash is listed at $48125M. | Mixed | Debt is meaningful, so flexibility depends on continued cash generation and disciplined funding. |
| Debt Service and Refinancing | Debt maturities paid in 2025: $500M 391% notes in Q2, $1000M 396% notes in Q3, and $2750M 418% notes in Q4; management wants to retain investment-grade credit ratings. | Strong | Staggered maturities reduce near-term refinancing pressure and support interest and debt repayment capacity. |
| Asset Quality | Acquisition spending in 2025 totaled $9332M net of cash acquired, and FARO Technologies was acquired for $9200M market capitalization; Indicor Instrumentation is expected to close in H2 2026. | Mixed | Goodwill and integration risk can rise after acquisitions, so asset quality should be watched closely. |
| Liabilities and Equity | Latest verified total liabilities and shareholders' equity were not supplied in the prompt. | Mixed | Without full balance-sheet detail, the cushion against losses is harder to judge precisely. |
Which balance-sheet risk matters most for AMETEK, Inc. (AME)?
Acquisition funding risk matters most. The biggest watch item is whether AMETEK, Inc. (AME) can keep financing deals and debt maturities without weakening its investment-grade posture or forcing less favorable refinancing.
- Current Exposure: $9332M spent on acquisitions in 2025, plus the planned $500B Indicor Instrumentation close in H2 2026.
- Protection: Management says capital deployment capacity exceeds $500B and it aims to retain investment-grade credit ratings.
- Warning Signal: Monitor whether acquisition spending and debt maturities begin to pressure liquidity or credit flexibility.
Capital Efficiency
Can AMETEK, Inc. earn adequate returns while funding growth?
Mixed to Strong. AMETEK, Inc. appears able to fund reinvestment largely from internal cash, with $170B in FY2025 free cash flow and 113% conversion. The key verification gap is that formal ROIC, ROE, and ROA were not supplied.
Return quality should be judged alongside leverage, asset intensity, capital expenditure, working capital needs, and any outside funding. AMETEK, Inc. can still look capital-efficient even with acquisitions or expansion, but the real test is whether operating cash flow keeps covering reinvestment without persistent debt growth, dilution, or strain on liquidity.
| Capital Measure | Latest Evidence | Quality Test | Investor Meaning |
|---|---|---|---|
| ROIC | Unavailable in supplied data. | Operating margins and capital efficiency cannot be verified from the provided return ratio set. | Investors cannot confirm whether invested capital is creating operating value from ROIC alone. |
| ROE and ROA | Unavailable in supplied data. | ROE would need leverage context; ROA would need asset intensity context. | Shareholder return quality and asset efficiency remain unverified, and leverage should not be treated as automatic strength. |
| Maintenance and Growth Investment | $1600M expected 2026 capital expenditures, or 2% of sales; $850M incremental invested during 2025 for technology innovation and market expansion. | The stated capex looks manageable, and the 2025 investment points to deliberate growth spending. | Capital needs appear moderate for sustaining operations while supporting expansion and technology upgrades. |
| Internal Funding Capacity | FY2025 free cash flow of $170B with 113% conversion; 2026 free cash flow conversion expected at 110% to 115% of net income. | Internal cash appears sufficient, with funding supported by cash generation rather than clear dependence on new outside capital. | That supports flexibility, limits dilution risk, and helps preserve shareholder returns if execution stays strong. |
Are AMETEK, Inc. returns on capital sustainable?
Likely yes, if cash conversion stays above net income and acquisition integration remains disciplined. The strongest durability driver is the AMETEK Growth Model, while heavy deal funding or weaker operating cash flow would be the clearest pressure point.
- Operating Source: Operational Excellence, plus mix gains from Strategic Acquisitions, Global and Market Expansion, and Technology Innovation.
- Funding Requirement: The largest verified need is $1600M of 2026 capital expenditures, alongside acquisition and integration spending.
- Durability Test: Returns weaken if free cash flow conversion falls below the 110% to 115% target or if debt and integration costs rise faster than cash generation.
AMETEK, Inc. also kept capital allocation active with a 10% increase in the quarterly cash dividend to $0.34 per share, but that is a payout decision, not proof of balance-sheet strength by itself. Expansion through Kern Microtechnik for $516M, FARO Technologies for $9200M, First Aviation Services with approximately $800M in annual revenue, and pending Indicor Instrumentation for approximately $500B in cash points to acquisition-led growth, so integration execution and funding discipline matter. For a broader ownership view, see Exploring AMETEK, Inc. (AME) Investor Profile: Who's Buying and Why?
Liquidity Watch
What warning signs could pressure AMETEK’s financial resilience?
Resilience is Strong, mainly because AMETEK, Inc. has a $387B Total Backlog, $220B in Q1 2026 Total Orders, and recurring demand from consumables, services, and aftermarket support. The most important verified warning sign is cash conversion volatility, especially the reported -2272% Operating Cash Flow Growth and -1920% Free Cash Flow Growth in FMP 2026-03-31 data.
AMETEK, Inc. should still be able to protect liquidity and fund core investment because demand is broad and working capital is already managed at 165% of sales. The pressure point is execution: if acquisition funding, integration costs, or cash conversion weaken at the same time, flexibility could tighten. For broader context on strategy, the company’s Mission Statement, Vision, & Core Values (2026) of AMETEK, Inc. (AME) also helps explain its long-term operating discipline.
| Pressure | Financial Effect | Existing Protection | Warning Signal |
|---|---|---|---|
| Revenue or Margin Pressure | Weaker sales or margins would reduce operating leverage, pressure earnings and cash flow, and make debt capacity less flexible. | Record backlog, Q1 2026 orders, 22% organic orders growth, and recurring revenue from consumables, services, and aftermarket support. | Falling revenue, margin compression, or weaker operating cash flow would confirm deterioration. |
| Working-Capital or Investment Pressure | Large receivables, inventory, capex, R&D, or acquisition spend could absorb cash and slow free cash flow. | Operating working capital at 165% of sales and internal funding capacity supported by ongoing customer demand. | Rising working capital, slower cash conversion, or heavier investment without cash return would be the signal to watch. |
| Interest or Refinancing Pressure | Higher financing needs would reduce free cash flow, tighten interest coverage, and limit flexibility if maturities or acquisition funding rise. | Business scale, recurring cash generation, and management’s stated expectation for 110% to 115% free cash flow conversion of net income in 2026. | Higher debt, lower free cash flow, or weaker liquidity after deal funding would show rising pressure. |
Which financial warning signs should investors monitor at AMETEK, Inc.?
Watch cash conversion first, then acquisition financing and integration execution. The confirmed deterioration signal is the negative FMP 2026-03-31 cash flow growth data; a future risk is pressure from the pending Indicor Instrumentation deal and multiple recent acquisitions.
Cash Conversion Weakness
The evidence is -2272% Operating Cash Flow Growth and -1920% Free Cash Flow Growth. That exposure matters because it can strain funding, even with strong backlog. The next metric is whether 2026 free cash flow conversion reaches 110% to 115% of net income.
Acquisition Funding and Integration Load
The exposure is the large cash deployment for the approximately $500B Indicor Instrumentation acquisition plus integration from FARO Technologies, Kern Microtechnik, LKC Technologies, and First Aviation Services. The main offset is diversified demand. Watch deal funding, integration costs, and post-deal cash generation.
Working-Capital Discipline Slips
This matters because working capital at 165% of sales can absorb cash if receivables or inventory rise faster than sales. The protection is recurring revenue and strong orders. Monitor operating cash flow, working-capital intensity, and conversion of backlog into cash.
Strong Financial Health
What does AMETEK, Inc. financial health mean for investors?
AMETEK, Inc. screens as Strong. The best factor is cash conversion, while the weakest is acquisition funding dependence. The key investment issue is whether disciplined capital deployment can keep supporting growth, margins, and backlog conversion. For mission context, see Mission Statement, Vision, & Core Values (2026) of AMETEK, Inc. (AME).
| Financial Factor | Rating | Evidence and Investor Meaning |
|---|---|---|
| Revenue and Earnings Quality | Strong | FY2025 Sales were $740B, Q1 2026 Sales were $193B, Total Orders were $220B, Organic Orders Growth was 22%, and Total Backlog was $387B, supporting durable demand and earnings visibility. |
| Profitability and Cash | Strong | Adjusted operating margins were 262% and FY2025 Free Cash Flow was $170B with 113% net income conversion, showing efficient profit turn and strong cash generation. |
| Balance Sheet and Liquidity | Mixed | Capital deployment capacity exceeds $500B and maturities were paid, but full balance-sheet liquidity and calculated net debt were not supplied, so leverage risk is harder to judge. |
| Capital Efficiency | Mixed | Cash generation supports reinvestment, but formal ROIC, ROE, and ROA were not supplied, and acquisition funding still needs discipline. |
| Financial Resilience | Strong | Backlog, recurring revenue, working-capital improvement, and cash conversion provide a solid buffer, though acquisition execution remains a pressure point. |
- What Supports the Thesis: Strong backlog, high organic order growth, and strong free cash flow conversion create a durable growth-and-cash profile.
- What Challenges the Thesis: Acquisition funding dependence and incomplete leverage disclosure leave some uncertainty around capital discipline.
- What to Monitor: Free Cash Flow conversion, operating working capital as a percentage of sales, and total debt after the Indicor Instrumentation acquisition closes.
For forecasts, scenarios, and valuation, the main question is whether AMETEK, Inc. can keep converting demand into cash while funding growth without weakening its balance-sheet profile.
FAQ
What Do Investors Ask About 's Financial Health?
Investors most often ask about the company's revenue quality, profitability, cash generation, debt, liquidity, capital efficiency, and ability to withstand financial pressure.
What does AMETEK’s 113% cash conversion mean?
It means FY2025 Free Cash Flow of $170B exceeded FY2025 Net Income of $148B For investors, that supports earnings quality because accounting profit converted into cash available for reinvestment, acquisitions, dividends, and debt management
How much flexibility does AMETEK’s capital capacity provide?
Management reported capital deployment capacity exceeding $500B while aiming to retain investment-grade credit ratings That supports deal-making flexibility, but the approximately $500B cash Indicor Instrumentation acquisition makes funding discipline the key balance-sheet item to monitor
Is AMETEK’s growth mostly organic or acquisition-driven?
The latest evidence shows both Q1 2026 Total Orders rose 23% year-over-year, with Organic Orders Growth of 22%, supporting organic momentum Acquisitions also remain central to the AMETEK Growth Model and add to revenue, scale, and integration requirements
Why does operating working capital matter for AMETEK?
Operating working capital shows how much cash is tied up in receivables, inventory, and operating needs AMETEK reported operating working capital at 165% of sales, a 30 basis point improvement versus prior year, which supports liquidity and cash conversion
How should investors view AMETEK’s debt position?
FMP enterprise value inputs at 2026-03-31 list Add Total Debt: $218B and Minus Cash And Cash Equivalents: $48125M AMETEK also paid 2025 maturities, but investors should avoid leverage conclusions without full balance-sheet ratios and post-acquisition financing details